Aadi Bioscience Stock Performance
| AADI Stock | USD 2.88 0.01 0.35% |
On a scale of 0 to 100, Aadi Bioscience holds a performance score of 9. The firm shows a Beta (market volatility) of 2.59, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Aadi Bioscience will likely underperform. Please check Aadi Bioscience's treynor ratio, expected short fall, and the relationship between the jensen alpha and potential upside , to make a quick decision on whether Aadi Bioscience's price patterns will revert.
Risk-Adjusted Performance
9 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Aadi Bioscience are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak fundamental indicators, Aadi Bioscience demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 39.1 M |
Aadi |
Aadi Bioscience Relative Risk vs. Return Landscape
If you would invest 196.00 in Aadi Bioscience on November 2, 2024 and sell it today you would earn a total of 92.00 from holding Aadi Bioscience or generate 46.94% return on investment over 90 days. Aadi Bioscience is currently generating 0.8805% in daily expected returns and assumes 7.4324% risk (volatility on return distribution) over the 90 days horizon. In different words, 66% of stocks are less volatile than Aadi, and 83% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Aadi Bioscience Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aadi Bioscience's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Aadi Bioscience, and traders can use it to determine the average amount a Aadi Bioscience's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1185
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | AADI | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.43 actual daily | 66 66% of assets are less volatile |
Expected Return
| 0.88 actual daily | 17 83% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Aadi Bioscience is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aadi Bioscience by adding it to a well-diversified portfolio.
Aadi Bioscience Fundamentals Growth
Aadi Stock prices reflect investors' perceptions of the future prospects and financial health of Aadi Bioscience, and Aadi Bioscience fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aadi Stock performance.
| Return On Equity | -0.66 | ||||
| Return On Asset | -0.35 | ||||
| Profit Margin | (2.46) % | ||||
| Operating Margin | (1.49) % | ||||
| Current Valuation | 9.41 M | ||||
| Shares Outstanding | 24.68 M | ||||
| Price To Book | 1.03 X | ||||
| Price To Sales | 2.84 X | ||||
| Revenue | 24.35 M | ||||
| EBITDA | (65.36 M) | ||||
| Cash And Equivalents | 118.74 M | ||||
| Cash Per Share | 5.65 X | ||||
| Total Debt | 1.27 M | ||||
| Debt To Equity | 0.02 % | ||||
| Book Value Per Share | 2.80 X | ||||
| Cash Flow From Operations | (59.66 M) | ||||
| Earnings Per Share | (2.28) X | ||||
| Total Asset | 132.42 M | ||||
| Retained Earnings | (268.96 M) | ||||
About Aadi Bioscience Performance
By evaluating Aadi Bioscience's fundamental ratios, stakeholders can gain valuable insights into Aadi Bioscience's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Aadi Bioscience has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Aadi Bioscience has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California. Aadi Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 67 people.Things to note about Aadi Bioscience performance evaluation
Checking the ongoing alerts about Aadi Bioscience for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Aadi Bioscience help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Aadi Bioscience is way too risky over 90 days horizon | |
| Aadi Bioscience appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 24.35 M. Net Loss for the year was (65.77 M) with loss before overhead, payroll, taxes, and interest of (27.54 M). | |
| Aadi Bioscience currently holds about 118.74 M in cash with (59.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.65, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Aadi Bioscience's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aadi Bioscience's stock is overvalued or undervalued compared to its peers.
- Examining Aadi Bioscience's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Aadi Bioscience's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aadi Bioscience's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Aadi Bioscience's stock. These opinions can provide insight into Aadi Bioscience's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Aadi Stock analysis
When running Aadi Bioscience's price analysis, check to measure Aadi Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aadi Bioscience is operating at the current time. Most of Aadi Bioscience's value examination focuses on studying past and present price action to predict the probability of Aadi Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aadi Bioscience's price. Additionally, you may evaluate how the addition of Aadi Bioscience to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |